Health
AstraZeneca in talks to shift COVID-19 vaccine production to Catalent factory – NYT – Reuters
AstraZeneca Plc (AZN.L) is in talks with the U.S. government to shift production of its COVID-19 vaccine from a troubled Baltimore plant to a factory owned by Catalent…
A vial labelled with the AstraZeneca coronavirus disease (COVID-19) vaccine is seen in this illustration picture taken March 19, 2021. REUTERS/Dado Ruvic/Illustration/File PhotoAstraZeneca Plc (AZN.L) is in talks with the U.S. government to shift production of its COVID-19 vaccine from a troubled Baltimore plant to a factory owned by Catalent Inc (CTLT.N), the New York Times reported, citing people familiar with the matter.
The British drugmaker has been on the lookout for an alternative production…
-
Noosa News19 hours agoNRL grand final quick hits: Reece Walsh creates magic after avoiding sin bin as Broncos survive Hunt, Reynolds injuries to win premiership
-
General19 hours agoHow the internet reacted to Brisbane Broncos winning the NRL grand final
-
Noosa News11 hours agoNew playground equipment encourages children to learn through ‘risky play’
-
General8 hours agoThree youths in police custody after fire at Ashley Youth Detention Centre in northern Tasmania